Identity
Pinealon is the experimental tripeptide Glu-Asp-Arg.
Selected study only; not a complete clinical review.
Peptide library
Pinealon
Your guide to this compound.
Mechanism illustrationEnlarge
Evidence in perspective
The rat developmental-injury model differs substantially from healthy adults seeking cognitive improvement. Learning and oxidative-stress measures in offspring cannot establish human prevention or treatment benefit.
About this assessment
Existing source snapshot critically reassessed.
Based on the selected source scope described in this profile, often an indexed abstract. Full methods and clinician sign-off remain pending; no systematic-review claim.
Editorial assessment · 2026-09-07
Who was studied
Rat offspring after experimental maternal hyperhomocysteinemia.
What the sources found
Selected learning and oxidative-stress measures improved in this animal model; human cognitive benefit was not established.
Regulatory scope
Current authorization for the exact product and jurisdiction was not independently checked in this snapshot. A clinical trial is not marketing authorization.
What remains unknown
Selected indexed primary-study abstract reviewed. Full methods, bias, all safety outcomes, product stability, current jurisdictional authorization and a comprehensive literature search remain outstanding. This is not a complete clinical review.
How it works
Pinealon is the experimental tripeptide Glu-Asp-Arg.
The study-specific findings below distinguish biological activity from demonstrated treatment benefit.
Preclinical research
The catalog primarily cites laboratory or animal research. Human benefit, a safe dose and long-term risks cannot be inferred from those findings.
Reported adverse effects
- Animal pregnancy experiments do not establish safety in human pregnancy or other populations.
Selected study only; not a complete clinical review.
Contraindications
- A complete contraindication and interaction review remains outstanding.
Preclinical research
The catalog primarily cites laboratory or animal research. Human benefit, a safe dose and long-term risks cannot be inferred from those findings.
Sources used for this snapshot
Claim-by-claim evidence
Benefits
Selected learning and oxidative-stress measures improved in this animal model; human cognitive benefit was not established.
Selected study only; not a complete clinical review.
Adverseeffects
Animal pregnancy experiments do not establish safety in human pregnancy or other populations.
Selected study only; not a complete clinical review.
References
Pinealon protects the rat offspring from prenatal hyperhomocysteinemia. 2012.
PMID: 22567179
Catalog review date: Sep 7, 2026. This date alone does not establish independent clinical review.